An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis

Clinical trial NCT00584779 · TERMINATED

Trial details

NCT number: NCT00584779
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

PK Properties Of Gabapentin In Subjects With Impaired Renal Function

Start date: 2007-10-01
Primary completion: 2007-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.